🧪
hypothesis

Stress-granule RNA-binding protein phase transition across ALS and FTD

Hypothesis

Stress-granule RNA-binding protein phase transition across ALS and FTD

Shared mechanism across ALS, FTD: Low-complexity RNA-binding proteins normally form reversible stress granules, but ALS/FTD-linked variants push granules toward persistent phase-separated assemblies that trap TDP-43 and impair RNA homeos.
🧬 TIA1;HNRNPA1;HNRNPA2B1🩺 multi🎯 Composite 78%💱 $0.53▲2.5%active
neurodegeneration
EvidenceStrong (88%)📖 3 cit🗣 1 debates 3 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.80 (15%) Evidence 0.74 (15%) Novelty 0.82 (12%) Feasibility 0.68 (12%) Impact 0.86 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.780 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite78%

🧪 Overview

Shared mechanism across ALS, FTD: Low-complexity RNA-binding proteins normally form reversible stress granules, but ALS/FTD-linked variants push granules toward persistent phase-separated assemblies that trap TDP-43 and impair RNA homeostasis. Different RBPs converge on the same granule-hardening mechanism.

Falsifiable prediction: Lowering TIA1 or hnRNPA1 granule persistence should shorten stress-granule half-life by at least 30% and reduce cytoplasmic TDP-43 recruitment in both ALS motor neurons and FTD cortical neurons carrying RBP/TDP-43 stress.

Proposed experiment: Introduce TIA1, HNRNPA1, or HNRNPA2B1 variants into isogenic motor and cortical neurons; apply ISR modulation or targeted RBP knockdown; image granule dynamics, FRAP recovery, TDP-43 recruitment, cryptic exon burden, and survival after stress.

Cross-disease confidence rationale: Direct TIA1 ALS/FTD evidence plus hnRNP prion-like domain ALS mechanism.

Internal SciDEX support: SciDEX support query found 41 matching hypotheses across 6 disease labels, including 41 with debate_count > 0.

...

🧬 Mechanism

🔗 Mechanism from KG for TIA1;HNRNPA1;HNRNPA2B1

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    GBA1_mutations["GBA1 mutations"] -->|increases risk| PD["PD"]
    TREM2_R47H_variant["TREM2 R47H variant"] -->|increases risk| Ad["Ad"]
    alpha_synuclein_fibrils["alpha-synuclein fibrils"] -->|activates| NLRP3_Inflammasome["NLRP3 Inflammasome"]
    TFEB_overexpression["TFEB overexpression"] -.->|inhibits| tau_A__pathology["tau/Aβ pathology"]
    TARDBP_MUTATIONS["TARDBP MUTATIONS"] -->|causes| ALS_FTD["ALS/FTD"]
    TDP_43_INCLUSIONS["TDP-43 INCLUSIONS"] -->|associated with| ALS_FTD_1["ALS/FTD"]
    NfL_reduction["NfL reduction"] -->|biomarker for| als["als"]
    TARDBP["TARDBP"] -->|cross disease mech| ALS["ALS"]
    TARDBP_2["TARDBP"] -->|cross disease mech| FTD["FTD"]
    TARDBP_3["TARDBP"] -->|cross disease mech| AD_LATE["AD/LATE"]
    h_cross_synth_tdp43_rna_p["h-cross-synth-tdp43-rna-proteostasis"] -->|proposes shared me| TARDBP_4["TARDBP"]
    SNCA["SNCA"] -->|cross disease mech| PD_5["PD"]
    style GBA1_mutations fill:#ce93d8,stroke:#333,color:#000
    style PD fill:#ef5350,stroke:#333,color:#000
    style TREM2_R47H_variant fill:#ce93d8,stroke:#333,color:#000
    style Ad fill:#ef5350,stroke:#333,color:#000
    style alpha_synuclein_fibrils fill:#4fc3f7,stroke:#333,color:#000
    style NLRP3_Inflammasome fill:#ce93d8,stroke:#333,color:#000
    style TFEB_overexpression fill:#4fc3f7,stroke:#333,color:#000
    style tau_A__pathology fill:#4fc3f7,stroke:#333,color:#000
    style TARDBP_MUTATIONS fill:#ce93d8,stroke:#333,color:#000
    style ALS_FTD fill:#ef5350,stroke:#333,color:#000
    style TDP_43_INCLUSIONS fill:#4fc3f7,stroke:#333,color:#000
    style ALS_FTD_1 fill:#ef5350,stroke:#333,color:#000
    style NfL_reduction fill:#ce93d8,stroke:#333,color:#000
    style als fill:#ef5350,stroke:#333,color:#000
    style TARDBP fill:#4fc3f7,stroke:#333,color:#000
    style ALS fill:#ef5350,stroke:#333,color:#000
    style TARDBP_2 fill:#4fc3f7,stroke:#333,color:#000
    style FTD fill:#ef5350,stroke:#333,color:#000
    style TARDBP_3 fill:#4fc3f7,stroke:#333,color:#000
    style AD_LATE fill:#ef5350,stroke:#333,color:#000
    style h_cross_synth_tdp43_rna_p fill:#4fc3f7,stroke:#333,color:#000
    style TARDBP_4 fill:#4fc3f7,stroke:#333,color:#000
    style SNCA fill:#4fc3f7,stroke:#333,color:#000
    style PD_5 fill:#ef5350,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix3 supports0 contradicts
Supports
TIA1 mutations in ALS/FTD promote phase separation and alter stress granules.
2017PMID:28817800high
Supports
hnRNPA2B1/hnRNPA1 prion-like domain mutations cause multisystem proteinopathy and ALS.
2013PMID:23455423high
Supports
TDP-43 pathology provides a shared ALS/FTD downstream anchor.
2006PMID:17023659medium
📖 Linked Papers (3)Export BibTeX ↗
TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
Neuron (2017) · PubMed:28817800 ↗
No figures
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Nature (2013) · PubMed:23455423 ↗
No figures
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Science (New York, N.Y.) (2006) · PubMed:17023659 ↗
No figures

🏥 Translation

🧬 3D Protein Structure — TIA1;HNRNPA1;HNRNPA2B1

No curated PDB or AlphaFold mapping for TIA1;HNRNPA1;HNRNPA2B1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TIA1;HNRNPA1;HNRNPA2B1 →

No DepMap CRISPR Chronos data found for TIA1;HNRNPA1;HNRNPA2B1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0004
Events (7d)
1
Price History
▲2.5%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations1 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
Lowering TIA1 or hnRNPA1 granule persistence should shorten stress-granule half-life by at least 30% and reduce cytoplasmic TDP-43 recruitment in both ALS motor neurons and FTD cortical neurons carryiIf this mechanism is real, then Lowering TIA1 or hnRNPA1 granule persistence should shorten stress-granule half-life by at least 30% and reduce cytoplasmic TDP-— no observation —pending0.74
🔮 Falsifiable Predictions (1)
pendingconf 74%
Lowering TIA1 or hnRNPA1 granule persistence should shorten stress-granule half-life by at least 30% and reduce cytoplasmic TDP-43 recruitment in both ALS motor neurons and FTD cortical neurons carrying RBP/TDP-43 stress.
Predicted outcome: If this mechanism is real, then Lowering TIA1 or hnRNPA1 granule persistence should shorten stress-granule half-life by at least 30% and reduce cytopl
Falsification: Falsified if the experiment produces results more than 20% below the predicted effect size
View on SciDEX ↗